Replimune Group, Inc. · NASDAQ:REPL

Xynos Konstantinos sold 16,198 Replimune Group, Inc. shares (Form 4)

Traded Nov 16, 2026 · Filed Nov 18, 2026

On Nov 16, 2026, Xynos Konstantinos (Chief Medical Officer) sold 16,198 Replimune Group, Inc. shares at US$21.60 for US$350K, leaving 208,017 shares. Filed Nov 18, 2026 (Form 4).

Sold
16,198 shares
Price
US$21.60
Value
US$350K
Holding after
208,017 shares
Trading plan
No
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 16, 2026Common StockSale16,198US$21.60208,017Direct

Source

Download original · View original at SEC

Related